chulacov19 mrna vaccine
Vaccineexperimental
Clinical trial activity
4 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 31, 2021 (NCT04566276)
Timeline
Indications
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05930730 | Phase 2 | Oct 9, 2023 | Chulalongkorn University, HIV-NAT Thai Red Cross AIDS Research Center |
| NCT05231369 | Phase 1 | Dec 10, 2022 | BioNet-Asia Co., Ltd., Chulalongkorn University, HIV-NAT Thai Red Cross AIDS Research Center |
| NCT05605470 | Phase 2 | Nov 21, 2022 | BioNet-Asia Co., Ltd., Chulalongkorn University, Southern Star Research Pty Ltd., Technovalia |
| NCT04566276 | Phase 1 | Jan 31, 2021 | Chulalongkorn University, Government of Thailand, Mahidol University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chulalongkorn University | Academic/Hospital | 4 | 3 | 2 | 2021 |
| BioNet-Asia Co., Ltd. | For profit | 2 | 0 | 2 | 2022 |
| HIV-NAT Thai Red Cross AIDS Research Center | Academic/Hospital | 2 | 0 | 2 | 2022 |
| Government of Thailand | Government | 1 | 0 | 1 | 2021 |
| Mahidol University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Southern Star Research Pty Ltd. | For profit | 1 | 0 | 1 | 2022 |
| Technovalia | For profit | 1 | 1 | 1 | 2022 |
7 organizations
Page 1 / 1